Key Events This Week
4 May: Intraday high with 7.99% surge to Rs.431.95
7 May: Mixed technical signals amid 6.53% price gain
8 May: Intraday high with 11.57% surge and gap up opening
8 May: Mojo Grade upgraded to Buy with score 70.0
Are Thyrocare Technologies Ltd latest results good or bad?
2026-05-08 19:20:05Thyrocare Technologies Ltd's latest financial results for the quarter ended March 2026 reflect a notable operational performance, showcasing significant growth in key metrics. The company reported a consolidated net profit of ₹47.12 crore, representing a substantial year-on-year growth of 117.14%. This impressive profit increase is complemented by a revenue figure of ₹223.95 crore, which marks a year-on-year growth of 19.66%. The operating margin for this quarter reached 33.53%, indicating operational efficiency and the highest margin recorded to date, up from 30.83% in the previous year. This margin expansion is attributed to improved pricing power and effective cost management strategies. Additionally, the return on equity (ROE) stands at 23.91%, highlighting the company's strong capital efficiency. Thyrocare's performance also indicates a sequential revenue growth of 14.53% from the previous quarter, ...
Read full news article
Thyrocare Technologies Ltd Sees Surge in Value Trading and Institutional Interest
2026-05-08 10:00:25Thyrocare Technologies Ltd witnessed a remarkable surge in trading activity on 8 May 2026, emerging as one of the most actively traded stocks by value on the Indian equity markets. The healthcare services company recorded a substantial 8.21% gain in a single day, driven by robust institutional participation and a strong order flow that pushed the stock close to its 52-week high. This performance notably outpaced both its sector and the broader Sensex index, signalling renewed investor confidence in the small-cap healthcare player.
Read full news article
Thyrocare Technologies Q4 FY26: Stellar Profit Surge Masks Valuation Concerns
2026-05-08 09:51:51Thyrocare Technologies Ltd., India's leading diagnostic services provider, delivered a remarkable fourth-quarter performance for FY26, with consolidated net profit surging 117.14% year-on-year to ₹47.12 crores, significantly outpacing market expectations. The Mumbai-based company, commanding a market capitalisation of ₹7,908.13 crores, reported its highest-ever quarterly revenue of ₹223.95 crores, representing a 19.66% year-on-year growth and a robust 14.53% sequential improvement.
Read full news article
Thyrocare Technologies Ltd Surges 11.57% to Day's High of Rs 521 — Outperforms Sector by 11.23 Percentage Points
2026-05-08 09:31:00The Sensex declined 0.37% on 08 Jun 2026 while Thyrocare Technologies Ltd surged 11.57%, marking a remarkable 11.23-percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which has been on a notable upward trajectory in recent days.
Read full news article









